Home › Astrocytoma › Washington › Seattle
Astrocytoma clinical trials in Seattle, WA
7 studies for Astrocytoma are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RecruitingPhase 3
- Swedish Medical Center-First Hill, Seattle
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
RecruitingPhase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Fred Hutch Cancer Center, Seattle
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Seattle Children's Hospital, Seattle
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Seattle Children's Hospital, Seattle
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Seattle Children's Hospital, Seattle
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Seattle Children's Hospital, Seattle
Astrocytoma trials in other cities
- Houston, TX15 studies
- Boston, MA13 studies
- New York City, NY10 studies
- Chicago, IL9 studies
- Philadelphia, PA7 studies
- Miami, FL7 studies
- Durham, NC7 studies
- San Francisco, CA6 studies
- Columbus, OH6 studies
- Aurora, CO6 studies
- Washington, DC5 studies
- Cincinnati, OH5 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)48 studies
- Prostate Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Breast Cancer37 studies
- Colorectal Cancer35 studies
- Lung Cancer34 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia22 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.